Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Tsui

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Cytometry. Part B, Clinical Cytometry|March 29, 2021
Lymphoid blasts with aberrant myeloid marker expression and BCR/ABL1: Is it mixed phenotype acute leukemia or B lymphoblastic leukemia?Kevin E Shopsowitz, Kalpesh Shah, Hubert Tsui
Reviews in Endocrine & Metabolic Disorders|September 23, 2003
Neuronal elements in the pathogenesis of type 1 diabetesHubert Tsui, Shawn Winer, George Jakowsky, et al.
Cancer Medicine|March 8, 2019
Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trialDavid E Spaner, Lindsay McCaw, Guizhei Wang, et al.
Trends in Molecular Medicine|September 29, 2007
'Sensing' autoimmunity in type 1 diabetesHubert Tsui, Rozita Razavi, Yin Chan, et al.
Molecular Cytogenetics|July 9, 2025
What the VAF? A guide to the interpretation of variant allele fraction, percent mosaicism, and copy number in cancerAdam C Smith, Hubert Tsui, Sila Usta, et al.
Annals of Hematology|November 28, 2022
EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemiaAdam Suleman, Hubert Tsui, Zeina Ghorab, et al.
Diabetes/Metabolism Research and Reviews|November 10, 2011
'Sensing' the link between type 1 and type 2 diabetesHubert Tsui, Geoffrey Paltser, Yin Chan, et al.
Annals of Hematology|October 2, 2021
Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenitaEugene Brailovski, Hubert Tsui, Yi-Bin Chen, et al.
Cancer Medicine|November 18, 2021
Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trialDavid E Spaner, Yuxuan Luo, Guizhei Wang, et al.
British Journal of Haematology|May 4, 2024
Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocationSigny Chow, Stephanie Lee, August Lin, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Cytometry. Part B, Clinical Cytometry|March 29, 2021
Lymphoid blasts with aberrant myeloid marker expression and BCR/ABL1: Is it mixed phenotype acute leukemia or B lymphoblastic leukemia?Kevin E Shopsowitz, Kalpesh Shah, Hubert Tsui
Reviews in Endocrine & Metabolic Disorders|September 23, 2003
Neuronal elements in the pathogenesis of type 1 diabetesHubert Tsui, Shawn Winer, George Jakowsky, et al.
Cancer Medicine|March 8, 2019
Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trialDavid E Spaner, Lindsay McCaw, Guizhei Wang, et al.
Trends in Molecular Medicine|September 29, 2007
'Sensing' autoimmunity in type 1 diabetesHubert Tsui, Rozita Razavi, Yin Chan, et al.
Molecular Cytogenetics|July 9, 2025
What the VAF? A guide to the interpretation of variant allele fraction, percent mosaicism, and copy number in cancerAdam C Smith, Hubert Tsui, Sila Usta, et al.
Annals of Hematology|November 28, 2022
EBV-positive diffuse large B-cell lymphoma following alemtuzumab therapy for T-cell prolymphocytic leukemiaAdam Suleman, Hubert Tsui, Zeina Ghorab, et al.
Diabetes/Metabolism Research and Reviews|November 10, 2011
'Sensing' the link between type 1 and type 2 diabetesHubert Tsui, Geoffrey Paltser, Yin Chan, et al.
Annals of Hematology|October 2, 2021
Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenitaEugene Brailovski, Hubert Tsui, Yi-Bin Chen, et al.
Cancer Medicine|November 18, 2021
Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trialDavid E Spaner, Yuxuan Luo, Guizhei Wang, et al.
British Journal of Haematology|May 4, 2024
Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocationSigny Chow, Stephanie Lee, August Lin, et al.
Pageof 5